DrugPatentWatch Database Preview
Celator Pharms Company Profile
What is the competitive landscape for CELATOR PHARMS, and what generic alternatives to CELATOR PHARMS drugs are available?
There are six US patents protecting CELATOR PHARMS drugs.
There are eighty patent family members on CELATOR PHARMS drugs in sixteen countries.
Summary for Celator Pharms
| International Patents: | 80 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Celator Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Celator Pharms | VYXEOS | cytarabine; daunorubicin | POWDER;IV (INFUSION) | 209401-001 | Aug 3, 2017 | RX | Yes | Yes | 8,518,437 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Celator Pharms | VYXEOS | cytarabine; daunorubicin | POWDER;IV (INFUSION) | 209401-001 | Aug 3, 2017 | RX | Yes | Yes | 8,092,828 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Celator Pharms | VYXEOS | cytarabine; daunorubicin | POWDER;IV (INFUSION) | 209401-001 | Aug 3, 2017 | RX | Yes | Yes | 8,431,806 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Celator Pharms | VYXEOS | cytarabine; daunorubicin | POWDER;IV (INFUSION) | 209401-001 | Aug 3, 2017 | RX | Yes | Yes | 8,022,279 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Celator Pharms
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,238,367 | Liposome loading with metal ions | ➤ Try a Free Trial |
| 7,744,921 | Liposome loading with metal ions | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Celator Pharms Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Spain | 2290333 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 03028697 | ➤ Try a Free Trial |
| Australia | 2002351626 | ➤ Try a Free Trial |
| Canada | 2564542 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
